Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03808298 · ClinicalTrials.gov registry record · Phase 1
Study to Investigate the Effect of Balovaptan on the QTC Interval in Healthy Subjects
A Phase 1 study of Healthy Volunteers, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 1
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT03808298 is a Phase 1 study of Healthy Volunteers that has completed, run by Hoffmann-La Roche. The registered enrollment target is 57 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03808298, a Phase 1 study of Healthy Volunteers, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
This was a single-center, multiple-dose, randomized, double-blind, placebo-controlled, positive-controlled, twelve sequence, 3-period cross-over study to investigate the effect of balovaptan on the QTc interval in healthy subjects.
Conditions Studied
Interventions
- DRUG Balovaptan therapeutic dose Treatment A
- DRUG Balovaptan supra-therapeutic dose Treatment B
- DRUG Active control [moxifloxacin] on Day 2 Treatment C
- DRUG Active control [Moxifloxacin] on Day 15 Treatment D
- DRUG Placebo for Balovaptan Treatment C
Study Locations (1)
Kansas
- PRA International Clinical Pharmacology Center (EDS US Clinic) - Lenexa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2019-02-07 |
| Est. Completion | 2019-07-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03808298
The ClinicalTrials.gov registry entry for NCT03808298 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (88% lower). The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 5 interventions - of which Balovaptan therapeutic dose Treatment A is the first listed.
NCT03808298 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT03808298 about?
NCT03808298 is a clinical study titled "Study to Investigate the Effect of Balovaptan on the QTC Interval in Healthy Subjects". This was a single-center, multiple-dose, randomized, double-blind, placebo-controlled, positive-controlled, twelve sequence, 3-period cross-over study to investigate the effect of balovaptan on the QTc interval in healthy subjects.
What is the current status of trial NCT03808298?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 57 participants. The study started on 2019-02-07. Estimated completion is 2019-07-13.
What conditions does trial NCT03808298 study?
This clinical trial studies the following conditions: Healthy Volunteers.
What interventions are being tested in trial NCT03808298?
The interventions under investigation include: Balovaptan therapeutic dose Treatment A (DRUG), Balovaptan supra-therapeutic dose Treatment B (DRUG), Active control [moxifloxacin] on Day 2 Treatment C (DRUG), Active control [Moxifloxacin] on Day 15 Treatment D (DRUG), Placebo for Balovaptan Treatment C (DRUG).
Who is sponsoring clinical trial NCT03808298?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03808298 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
RECRUITING · Phase 1
-
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants
RECRUITING · Phase 1
-
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
RECRUITING · Phase 1
-
Classroom Break, Cognition, and Fitness in Elementary School Children
RECRUITING · Phase 1
-
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.